Skip to main content
Clinical Trials/NCT03385642
NCT03385642
Completed
Not Applicable

Follow-Up Study Evaluating the Long-Term Outcomes of ChondroMimetic in the Treatment of Osteochondral Defects (Extension Study of Protocol 0MCM0107)

Collagen Solutions1 site in 1 country15 target enrollmentMay 29, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Osteochondral Defect
Sponsor
Collagen Solutions
Enrollment
15
Locations
1
Primary Endpoint
Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

To investigate the long-term efficacy and safety of the medical device, ChondroMimetic, in subjects who were treated in the interventional study 0MCM0107 for osteochondral defects of the knee.

Detailed Description

This is an open-label, single center, extension study to the previous interventional study 0MCM0107 designed to investigate the long-term efficacy and safety of the medical device, ChondroMimetic, in the treatment of osteochondral defects of the knee. Follow-up to 6-months was completed as part of study 0MCM0107. All 17 subjects who received ChondroMimetic in study 0MCM0107 are eligible for enrolment into this extension study regardless of their current follow-up period.

Registry
clinicaltrials.gov
Start Date
May 29, 2017
End Date
February 22, 2018
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Collagen Solutions
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]

Time Frame: 0MCM0107 Baseline and through study completion, an average of approximately 8 years follow-up

Long-term safety will be assessed by physical and knee examination, and subject history since original treatment in study 0MCM0107

Change from 0MCM0107 baseline in Modified Cincinnati Rating System

Time Frame: 0MCM0107 Baseline and through study completion, an average of approximately 8 years follow-up

Subjective score designed to provide information regarding a patient's functional and clinical status after knee surgery.

KOOS (Knee injury and Osteoarthritis Outcome Score

Time Frame: Through study completion, an average of approximately 8 years follow-up

Subjective score designed to provide information regarding a patient's functional and clinical status after knee surgery.

Cartilage repair tissue quantity and quality using 3D quantitative MRI analysis

Time Frame: Through study completion, an average of approximately 8 years follow-up

Morphological segmentation utilizing a programmed anatomical atlas for all bone and cartilage structures will be used to assess defect filling (using previous MRI scans from study 0MCM0107 as reference), and T2 mapping for cartilage repair tissue quality.

Osteochondral defect repair assessment

Time Frame: Through study completion, an average of approximately 8 years follow-up

Defect repair outcomes will be assessed using the magnetic resonance observation of cartilage repair tissue (MOCART) subjective radiological scoring system.

Study Sites (1)

Loading locations...

Similar Trials